FilingSEC EDGAR8-K
Telomir Pharmaceuticals Publishes Preclinical Study Results for Telomir-Zn
· SEC accepted
StagePreclinical
Filing content
The company announced the publication of preclinical research in the International Journal of Molecular Sciences, demonstrating Telomir-Zn's ability to improve visual function and restore retinal structure in an AMD model.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…